SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641489-23-000014
Filing Date
2023-04-26
Accepted
2023-04-26 16:42:36
Documents
22

Document Format Files

Seq Description Document Type Size
1 DEF 14A vtvt-20230426.htm   iXBRL DEF 14A 664933
6 vtvt-20230426_g1.jpg GRAPHIC 116073
7 vtvt-20230426_g2.jpg GRAPHIC 120640
8 vtvt-20230426_g3.jpg GRAPHIC 163380
9 vtvt-20230426_g4.jpg GRAPHIC 119019
10 vtvt-20230426_g5.jpg GRAPHIC 158611
11 vtvt-20230426_g6.jpg GRAPHIC 152625
12 vtvt-20230426_g7.jpg GRAPHIC 335927
13 vtvt-20230426_g8.jpg GRAPHIC 239989
  Complete submission text file 0001641489-23-000014.txt   4816665

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20230426.xsd EX-101.SCH 5054
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20230426_def.xml EX-101.DEF 7707
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20230426_lab.xml EX-101.LAB 11170
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20230426_pre.xml EX-101.PRE 6949
16 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20230426_htm.xml XML 227046
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37524 | Film No.: 23850420
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences